V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002757 | 240010348 | 1.63 | 62.8 | 03 | null | 2019-01-09 | null | N | null | PEG INTERFERON | 101368299 |
| 240002772 | 240010351 | 1.79 | 58.4 | Curative (C) | 2019-01-15 | 2019-01-19 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | IBRUTINIB | 101375285 |
| 240002775 | 240010352 | 1.54 | 69 | Curative (C) | 2017-02-12 | 2017-02-16 | CHLORAMBUCIL + OBINUTUZUMAB | N | null | FLAIR TRIAL | 101733692 |
| 240002776 | 240010353 | null | null | Curative (C) | 2017-09-05 | 2017-10-02 | null | 01 | N | AML MYECHILD 01 HD ARAC | 100573657 |
| 240002777 | 240010354 | 1.6 | 121.1 | Curative (C) | null | 2019-11-09 | Niraparib | N | N | IVE-R | 101584198 |
| 240002798 | 240010357 | 1.78 | 81.6 | Palliative (P) | 2017-05-14 | 2017-05-15 | LCHIV SL-IT | 02 | N | BUSULFAN | 100442675 |
| 240002800 | 240010358 | 1.82 | 53.3 | Curative (C) | 2020-02-29 | 2020-03-07 | AML MyeChild 01 IT Cyt | 02 | N | FLAG + IDARUBICIN | 101636520 |
| 240002815 | 240010360 | 1.5 | 0 | Disease modification (D) | null | 2020-03-06 | null | 02 | N | CYTARABINE + FLUDARABINE + IDARUBICIN | 100137843 |
| 240002817 | 240010361 | 1.65 | 66.6 | null | 2020-01-19 | 2020-01-19 | AML Downs HA | null | null | CISPLATIN + GEMCITABINE | 100255854 |
| 240002831 | 240010364 | 1.58 | 89.2 | Curative (C) | 2020-11-05 | 2020-12-10 | VEDex | 01 | N | CLADRIBINE | 100005624 |
| 240002839 | 240010366 | 1.73 | 55 | Curative (C) | 2018-12-23 | 2018-12-25 | null | 01 | null | MELPHALAN | 100264509 |
| 240002844 | 240010368 | 1.64 | 122 | Curative (C) | 2021-09-04 | 2021-12-01 | FLAG + Idarubicin | null | N | CYTARABINE + FLUDARABINE | 100157504 |
| 240002846 | 240010370 | 0 | 113 | Adjuvant (A) | 2022-04-29 | 2022-04-29 | CNS PNET 5 Medbl L/StRsk Mnt B | 01 | N | POMALIDOMIDE | 100462976 |
| 240002847 | 240010371 | 1.68 | 112.9 | Curative (C) | 2021-12-14 | 2022-01-08 | null | null | N | AZACITIDINE + VENETOCLAX | 100938743 |
| 240000237 | 240010374 | 1.84 | 106 | Palliative (P) | 2021-10-15 | 2021-10-17 | GEMTUZUMAB OZOGAMICIN | N | null | ALEMTUZUMAB + CYCLOPHOSPHAMIDE + FLUDARABINE | 100510652 |
| 240000434 | 240010376 | 1.72 | 72.6 | Curative (C) | null | 2019-03-20 | PEG INTERFERON | null | N | RUXOLITINIB | 100244785 |
| 240000708 | 240010381 | 1.65 | 92.1 | Disease modification (D) | null | 2021-12-17 | Rituximab + Venetoclax | N | N | VINBLASTINE | 101863435 |
| 240001015 | 240010383 | 1.67 | 79.2 | null | 2016-07-27 | 2016-07-27 | null | 02 | null | ALL UKALL2011 DEL INT C | 101156464 |
| 240001123 | 240010384 | 1.68 | 88.5 | 03 | 2019-07-27 | 2019-08-16 | CVP R | 02 | null | NOT MATCHED | 101055953 |
| 240001189 | 240010385 | 1.6 | 79 | Adjuvant (A) | null | 2022-05-11 | CYTARABINE + DAUNORUBICIN + Gemtuzumab Ozogamicin | null | null | METHOTREXATE INTRATHECAL | 101530642 |
| 240001287 | 240010386 | null | 76.55 | Adjuvant (A) | 2017-08-22 | 2017-08-30 | DA 3+8 | 02 | N | LIPOSOMAL DAUNORUBICIN + LIPOSOMAL CYTARABINE (VYXEOS) | 100843054 |
| 240001659 | 240010388 | 1.78 | 57.7 | null | 2018-10-08 | 2018-10-09 | ATG + Busulfan + Fludarabine | 02 | null | ANAGRELIDE | 100079215 |
| 240001816 | 240010389 | 0 | 44 | null | 2018-10-09 | 2018-10-12 | BEAM | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + RITUXIMAB + VINCRISTINE | 101132644 |
| 240002007 | 240010391 | 0 | 52 | 03 | 2018-11-06 | 2018-11-07 | ALL UKALL2011 Maintenance A2 | N | null | DABRAFENIB | 100038688 |
| 240002152 | 240010392 | 1.63 | 62 | null | 2021-12-21 | 2022-01-04 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | null | N | RITUXIMAB + VENETOCLAX | 100343792 |
| 240002338 | 240010394 | 1.53 | 86.2 | Curative (C) | 2018-05-09 | 2018-05-09 | null | null | null | RUXOLITINIB | 101804494 |
| 240002801 | 240010395 | 0 | 63.9 | 03 | 2021-02-13 | 2021-02-24 | IDELALISIB | 02 | N | CYTARABINE + FLUDARABINE + IDARUBICIN | 100815906 |
| 240000907 | 240010510 | 1.66 | 73.65 | null | null | 2019-05-31 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100119530 |
| 240000923 | 240010522 | null | null | null | null | 2017-03-19 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100469528 |
| 240000936 | 240010526 | 1.56 | 94 | null | null | 2018-06-02 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101506948 |
| 240000945 | 240010529 | 1.79 | 77 | null | null | 2018-09-02 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101209329 |
| 240000960 | 240010536 | null | null | null | null | 2017-05-19 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101321769 |
| 240000997 | 240010552 | null | null | null | null | 2019-03-16 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101737204 |
| 240001001 | 240010554 | null | null | null | null | 2016-08-07 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101519572 |
| 240001009 | 240010555 | null | null | null | null | 2019-06-30 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100510139 |
| 240001022 | 240010561 | null | null | null | null | 2017-04-15 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100643114 |
| 240001047 | 240010571 | null | null | null | null | 2018-01-27 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101566637 |
| 240001083 | 240010584 | null | null | null | null | 2017-05-28 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100277792 |
| 240001087 | 240010586 | null | null | Curative (C) | null | 2019-01-05 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100860271 |
| 240001095 | 240010589 | null | null | Curative (C) | null | 2018-06-07 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101404275 |
| 240001100 | 240010590 | 1.58 | 74.3 | null | null | 2020-06-06 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100890167 |
| 240001101 | 240010591 | null | null | null | null | 2020-11-27 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100498941 |
| 240001114 | 240010594 | null | null | null | null | 2019-01-31 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101336567 |
| 240001119 | 240010595 | null | null | null | null | 2018-12-29 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101489475 |
| 240001128 | 240010598 | null | null | null | null | 2016-03-21 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100562267 |
| 240001142 | 240010602 | null | null | null | null | 2019-04-21 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101172737 |
| 240001154 | 240010607 | null | null | null | 2018-02-08 | 2018-03-15 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100656771 |
| 240001155 | 240010608 | null | null | null | 2017-10-09 | 2019-08-17 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100273816 |
| 240001161 | 240010610 | 1.82 | 94.25 | null | null | 2017-05-25 | null | 02 | null | CYTARABINE | 101087768 |
| 240001173 | 240010612 | 1.7 | 42.3 | null | null | 2016-07-28 | null | 02 | null | HYDROXYCARBAMIDE | 101104922 |